Inclusive drugs: designing clinical trials for the pregnant population
Experts share why protection by the exclusion of pregnant people leads to a lack of evidence-based medicine and ways to improve clinical trial conduct....
19 January, 2023
Health Equity
Association of Clinical Research Professionals’ response to FDA draft guidance on diversity in clinical trials
Increased diversity in clinical trials should be a requirement, not a suggestion....
12 January, 2023
The long-term impact of COVID-19 on clinical trials: Part 1
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
11 January, 2023
Raising minority enrollment with creativity and collaboration
The need for more diversity in clinical trials is being increasingly emphasized, but more creative and collaborative recruitment approaches may be needed to make trials more diverse....
09 January, 2023
Enhancing diversity in clinical trial populations: An agency-industry perspective
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
31 December, 2022
A new HIV treatment shot is given only twice a year. It could be a ‘game changer’
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens....
30 December, 2022
Two straightforward ways to improve DE&I in clinical trials
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
27 December, 2022
Innovate to increase diversity in cancer clinical trials
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
20 December, 2022
Don’t wait on legislation to begin leveraging DEI
Research programs and studies that are built on a DEI foundation will inevitably have a positive influence on the trajectory of goals that include increasing diversity in clinical trials and cultivating inclusive environments for the biomedical research workforce....
16 December, 2022
Predicting the clinical trials of the future: Top 4 trends to watch
Predictions for how clinical trials will evolve to better serve patients in 2023 and beyond....
15 December, 2022